Divi's Laboratories share news and announcements
NSE: DIVISLABBSE: 532488Pharmaceuticals & BiotechnologyLarge Cap
Last close ₹8,950.00down ₹212.00 (2.31%)BSE ₹8,984.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹9,162.00.
52-week range of traded prices to 23 Oct 2026
₹5,647.50Low, 2 Apr 2026₹9,740.00High, 24 Sep 2026
- Next results date: the board meets on 7 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,37,594 Cr50th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 1 Aug 2026
- 81.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 14.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 1 Aug 2026
- 18.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 1 Aug 2026
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,20,26160.6% delivered
Divi's Laboratories orders, deals and press releases
49 filed, newest first.
Sep 2023
May 2023
Aug 2016
May 2016
Feb 2016
Oct 2015
Sep 2015
Aug 2015
May 2015
Jan 2015
Nov 2014
Aug 2014
May 2014
Feb 2014
Aug 2013
May 2013
Feb 2013
Nov 2012
Aug 2012
May 2012
Mar 2012
6 Mar · Business
Compensation Committee of Board of Directors on March 05, 2012 made the allotment of 31180 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132734290 equity shares from 132703110 equity shares of face value Rs. 2/- each.
Jan 2012
Nov 2011
1 Nov · Business
Compensation Committee of Board of Directors in its meeting held on November 01, 2011 made the allotment of 26560 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the Company will get increased to 132703110 equity shares from 132676550 equity shares of face value Rs. 2/- each.
Aug 2011
6 Aug · Business
Compensation Committee of Board of Directors in its meeting held on August 06, 2011 made the allotment of 26520 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the Company will get increased to 132676550 equity shares from 132650030 equity shares of face value Rs. 2/- each.
May 2011
23 May · Business
Compensation Committee of Board of Directors in its meeting held on May 20, 2011 made the allotment of 54920 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132650030 equity shares from 132595110 equity shares of face value Rs. 2/- each.
Feb 2011
4 Feb · Business
Compensation Committee of Board of Directors in its meeting held on February 4, 2011 made the allotment of 29690 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132595110 equity shares from 132565420 equity shares of face value Rs. 2/- each.
Nov 2010
9 Nov · Business
Compensation Committee of Board of Directors in its meeting held on November 09, 2010 made the allotment of 34180 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132565420 equity shares from 132531240 equity shares of face value Rs.2/- each.
Aug 2010
May 2010
Jan 2010
29 Jan · Business
Press release dated January 29, 2010, titled "Divi's Labs earns an Income of Rs.649 crores for 9M of FY10". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
31 Jul · Business
Press release dated July 31, 2009 titled "Divi's Labs earns an Income of Rs. 218 crores in Q1". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
8 Jun · Business
Vide its letter dated June 06, 2009 regarding the press release, titled "Divi's Labs earns a PAT of Rs.417 for the year 2008-09 And declares 1:1 bonus". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
24 Jan · Business
Press release, dated January 24, 2009 titled "Divi's Labs PAT for 9 months grows by 21% to Rs.309 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
29 Oct · Business
Press release, titled "Divi's Labs PAT for Q2 grows by 49% to Rs.135 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
26 Jul · Business
Press release, titled "Divi's Labs PAT for Q1 grows by 45% to Rs.94 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
9 Jun · Business
Press release, titled "Divi's Labs PAT for FY08 grows by 87% to Rs.348 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
28 Jan · Business
Press release, titled "Divi's Labs PAT for Q3 grows by 216% to Rs.99 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
27 Oct · Business
Press release which is as follows: "Divi's laboratories has earned a PAT of Rs.91 crores on consolidated basis for the second quarter ending 30th September, 2007. Total income for the quarter grew by 48% to Rs.245 crores. For the corresponding quarter of last year, the company earned a PAT of Rs.30 crores on a total income of Rs.165 crores. For the current half-year, Divi's earned a PAT of Rs.156 crores on income of Rs.475 crores as against a PAT of Rs.56 crores and income of Rs.330 crores during the corresponding previous half-year".
Jul 2007
30 Jul · Business
Press release titled "Divi's Labs PAT for Q1 grows by 153% to Rs.65 crores". which is has follows "Divi's Laboratories has earned a PAT of Rs.65 crores on a consolidated basis for the quarter ending 30th June, 2007. The total income grew by 39% to Rs.230 crores. An amount of Rs.2 crores has been charged as expense during the year on account of Stock options. For the first quarter of last year, it earned a PAT of Rs.26 crores on a total income of Rs.165 crores during the last year".
May 2007
23 May · Business
Press release titled "Divi's Labs PAT for FY07 grows by 167% to Rs.186 crores". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2007
27 Jan · Business
Press release, titled "Divi's Labs Q3 total income grows by 38% to Rs.152 crores". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.